- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
DaVita HealthCare Partners Inc(DVA)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for DVA
11/13/2026: DVA (2-star) is a SELL. SELL for 1 day. Simulated Profits (-10.40%). Updated daily EoD!
DaVita HealthCare Partners Inc is a specialized healthcare services company operating a leading network of outpatient dialysis clinics across the United States. The company's main strengths lie in its deep clinical expertise, dense facility footprint, and reliable generation of free cash flow driven by essential patient treatments. Its primary growth story centers on expanding home dialysis modalities and value-based integrated care partnerships. Key risks include heavy reliance on government reimbursement rates, potential regulatory compliance scrutiny, and sensitivity to commercial payer mix. The stock suits value-oriented investors seeking stable, cash-generative healthcare exposure, with ongoing monitoring required around labor costs and federal healthcare policy shifts.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Revenue growth is characteristically slow and steady rather than high-octane. |
| Momentum investor | Strong fit while signal remains positive | The stock can experience sustained upward trends driven by share buybacks and earnings beats when market sentiment is favorable. |
| Value investor | Strong fit | The company trades at reasonable valuation multiples backed by consistent cash generation and earnings quality. |
| Dividend investor | Weak fit | DaVita does not pay a regular cash dividend, favoring share repurchases instead. |
| Low-risk investor | Mixed fit | While demand for dialysis is defensive, regulatory and reimbursement uncertainties introduce structural risks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock experiences moderate price swings influenced by broader market conditions and healthcare policy news. |
| Valuation risk | Low | Trading multiples typically reflect stable, predictable cash flows without extreme speculative premiums. |
| Competition risk (duopoly and specialized providers) | Medium | DaVita operates in a concentrated market alongside major peers like Fresenius, limiting aggressive market share grabs. |
| Business quality | Strong | The company maintains high operating margins and strong economic moats in specialized outpatient care. |
| Dividend income | Low / none | Income-focused investors receive no direct cash return via dividends. |
| Execution risk | Medium | Operational success depends heavily on managing clinical labor costs and maintaining stringent regulatory compliance. |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 10.98B USD | Price to earnings Ratio 13.21 | 1Y Target Price 222.29 |
Price to earnings Ratio 13.21 | 1Y Target Price 222.29 | ||
Volume (30-day avg) 777.1K shares | Beta 0.86 | 52 Weeks Range 101.00 - 247.49 | Updated Date 11/15/2026 |
52 Weeks Range 101.00 - 247.49 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 13.21 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Care Facilities
- BUY participation
- 88.9%
- Active BUY / eligible
- 8 / 9
- 30-Day BUY Count Change
- +6
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 4% | Avg. Invested days 47 | Today’s Advisory SELL |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| U.S. Dialysis and Patient Services | Outpatient hemodialysis treatments, peritoneal dialysis services, and administered pharmaceuticals in domestic clinics. | This is the core engine of the company, generating recurring revenue from regular patient visits. |
| Ancillary Services and Strategic Initiatives | Integrated kidney care arrangements, clinical laboratory testing, and international dialysis operations. | Provides secondary revenue streams and positions the company for value-based care reimbursement models. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-10-29 | When After Market | Estimate 3.78 | Actual 3.82 |
Profitability
Profit Margin 6.49% | Operating Margin (TTM) 15.17% |
Management Effectiveness
Return on Assets (TTM) 7.59% | Return on Equity (TTM) 96.79% |
Valuation
Trailing PE 13.21 | Forward PE 9.48 | Enterprise Value 23.81B | Price to Sales(TTM) 0.78 |
Enterprise Value 23.81B | Price to Sales(TTM) 0.78 | ||
Enterprise Value to Revenue 1.68 | Enterprise Value to EBITDA 8.48 | Shares Outstanding 62.90M | Shares Floating 33.44M |
Shares Outstanding 62.90M | Shares Floating 33.44M | ||
Percent Insiders 47.91 | Percent Institutions 51.3 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

